No menu items!
Thursday, June 25, 2026

cervical

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

Reimagining HRTech: Sonali Chowdhry on Building Scalable, People-First Workforce Solutions

As organizations navigate rapid digital transformation, the need for intelligent, integrated, and people-centric HR systems has never been more...
- Advertisement -spot_img